A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined with Paclitaxel and Pegfilgrastim: A Feasibility Study in Patients with Untreated Stage III and IV Ovarian, Tubal or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

PURPOSE: Dose-dense regimens have been shown to improve outcome when given as adjuvant therapy to patients with breast cancer compared with their three weekly counterparts. We investigated the feasibility of a dose-dense regimen with carboplatin/paclitaxel followed by pegfilgrastim in patients with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tiersten, Amy D., Sill, Michael W., Knight, Danielle, Muggia, Franco, Garcia, Agustin A., Swensen, Ron, Warshal, David P., Mannel, Robert S., Fracasso, Paula M.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2918716/
https://ncbi.nlm.nih.gov/pubmed/20547415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2010.05.020
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares